Authors' reply

BMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7043.1421 (Published 01 June 1996) Cite this as: BMJ 1996;312:1421
  1. Bryce A Kiberd,
  2. Kailash K Jindal
  1. Associate professor Associate professor Department of Medicine, Dalhousie University, Halifax, Nova Scotia Canada B3H 2Y9

    EDITOR,—The most important focus of our paper was to critically evaluate the assumptions that were required to make screening cost effective.1 It would seem that Dr Borch-Johnsen and colleagues agree. Their paper, however, did not adequately examine the specificity and sensitivity of screening; furthermore it examined screening and treatment versus no specific treatment.2 This latter approach should be considered obsolete since the effects of angiotensin converting enzyme inhibition to reduce progressive renal failure …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription